Literature DB >> 27129983

The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics.

Peiyong Jiang1, Y M Dennis Lo2.   

Abstract

The discovery of cell-free tumor and fetal DNA molecules in the plasma of cancer patients and pregnant women, respectively, has opened up exciting opportunities in molecular diagnosis. The understanding of the biological properties of circulating cell-free DNA (cfDNA) molecules would be essential for us to make the best use of such molecules in different clinical settings. In this review we start by exploring the technologies that have been used for analyzing the size profiles of cfDNA in plasma. We then review the size profiles of cfDNA in different clinical scenarios, including cancer, pregnancy, transplantation, and autoimmune diseases. Finally, we discuss the potential diagnostic applications of plasma DNA size profiling.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cell-free DNA; liquid biopsy; size profile

Mesh:

Substances:

Year:  2016        PMID: 27129983     DOI: 10.1016/j.tig.2016.03.009

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  81 in total

1.  Enhanced detection of circulating tumor DNA by fragment size analysis.

Authors:  Florent Mouliere; Dineika Chandrananda; Anna M Piskorz; Elizabeth K Moore; James Morris; Lise Barlebo Ahlborn; Richard Mair; Teodora Goranova; Francesco Marass; Katrin Heider; Jonathan C M Wan; Anna Supernat; Irena Hudecova; Ioannis Gounaris; Susana Ros; Mercedes Jimenez-Linan; Javier Garcia-Corbacho; Keval Patel; Olga Østrup; Suzanne Murphy; Matthew D Eldridge; Davina Gale; Grant D Stewart; Johanna Burge; Wendy N Cooper; Michiel S van der Heijden; Charles E Massie; Colin Watts; Pippa Corrie; Simon Pacey; Kevin M Brindle; Richard D Baird; Morten Mau-Sørensen; Christine A Parkinson; Christopher G Smith; James D Brenton; Nitzan Rosenfeld
Journal:  Sci Transl Med       Date:  2018-11-07       Impact factor: 17.956

Review 2.  Circulating cell-free DNA for non-invasive cancer management.

Authors:  Caitlin M Stewart; Dana W Y Tsui
Journal:  Cancer Genet       Date:  2018-03-11

3.  Sequencing of short cfDNA fragments in NIPT improves fetal fraction with higher maternal BMI and early gestational age.

Authors:  Longwei Qiao; Qin Zhang; Yuting Liang; Ang Gao; Yang Ding; Nannan Zhao; Wei Zhang; Hong Li; Yaojuan Lu; Ting Wang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 4.  The role of neutrophil activation in determining the outcome of pregnancy and modulation by hormones and/or cytokines.

Authors:  S Hahn; P Hasler; L Vokalova; S V van Breda; O Lapaire; N G Than; I Hoesli; S W Rossi
Journal:  Clin Exp Immunol       Date:  2019-03-13       Impact factor: 4.330

Review 5.  Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA).

Authors:  Re-I Chin; Kevin Chen; Abul Usmani; Chanelle Chua; Peter K Harris; Michael S Binkley; Tej D Azad; Jonathan C Dudley; Aadel A Chaudhuri
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

Review 6.  Liquid biopsies in pancreatic cancer.

Authors:  Nabiollah Kamyabi; Vincent Bernard; Anirban Maitra
Journal:  Expert Rev Anticancer Ther       Date:  2019-09-26       Impact factor: 4.512

Review 7.  DNA as a self-antigen: nature and regulation.

Authors:  Chetna Soni; Boris Reizis
Journal:  Curr Opin Immunol       Date:  2018-09-24       Impact factor: 7.486

8.  Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma.

Authors:  Gilbert J Cote; Caitlin Evers; Mimi I Hu; Elizabeth G Grubbs; Michelle D Williams; Tao Hai; Dzifa Y Duose; Michal R Houston; Jacquelin H Bui; Meenakshi Mehrotra; Steven G Waguespack; Naifa L Busaidy; Maria E Cabanillas; Mouhammed Amir Habra; Rajyalakshmi Luthra; Steven I Sherman
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

9.  Fragment Size Analysis May Distinguish Clonal Hematopoiesis from Tumor-Derived Mutations in Cell-Free DNA.

Authors:  Francesco Marass; Dennis Stephens; Ryan Ptashkin; Ahmet Zehir; Michael F Berger; David B Solit; Luis A Diaz; Dana W Y Tsui
Journal:  Clin Chem       Date:  2020-04-01       Impact factor: 8.327

10.  Experimental factors are associated with fetal fraction in size selection noninvasive prenatal testing.

Authors:  Longwei Qiao; Jun Mao; Minjuan Liu; Yinghua Liu; Xiaoyan Song; Hui Tang; Qing Zhang; Hong Li; Yaojuan Lu; Yuting Liang; Ting Wang
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.